



Целью данной работы является исследование кинетики распределения мо-
ноклонального антитела, соединенного с радионуклидом в организме человека и 
создание программного обеспечения, которое будет использоваться для расчета 
поглощенной дозы в зависимости от источника ионизирующего излучения и мо-
ноклоального антитела. 
Для проведения исследований было выбрано моноклоальное антитело, кото-
рое используется для таргетной терапии. К нему был присоединен радионуклид, 
который в последствии воздействовал ионизирующим излучением на опухоле-
вые клетки. Было исследовано, какую дозу радиации получают органы, взаимо-
действовавшие с данным антителом. С помощью созданного програмного обес-
печения была рассчитана поглощенная доза в исследуемом органе человека. 
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Abstract. In this study, we consider a comprehensive approach to the selection of an op-
timal treatment plan for a patient with nasopharyngeal cancer. The approach is based on the 
evaluation of not only dosimetric radiation parameters but also radiobiological ones. Hence, 
it provides information about long-term consequences that is crucial for a qualitative radio-
therapy. 
 
Despite the rapid development of technologies that promote high-precision target 
volume irradiation, it remains essential to consider a late normal tissue response since 
the radiation-related complications have a tremendous impact on the quality of life. 
The complications may depend on a decision regarding a type of ionizing radiation [1-
2]. Nevertheless, prescribing the treatment for a patient, insurance companies mostly 
follow the ALARA principle (as low as reasonably achievable) that states achieving of 
the greatest benefit for the patient at the lowest expenses. Such a solution is not always 
the most effective one in terms of achieving a therapeutic effect. Thus, an integrated 
approach based on the analysis of physical (dosimetric) parameters as well as radiobi-
ological calculations should take place in a real practice in order to determine the most 




In the research, we compared irradiation plans for both proton and photon radio-
therapy for a patient with nasopharyngeal cancer. All the irradiation plans were de-
signed in separate planning systems and then, imported into the VARIAN Eclipse 11.0 
planning system to be able to compare and analyze them. As the result, we received 
Dose-Volume Histograms (DVHs) reflecting the dose distributions in both tumor and 
organs at risk. These results were compatible with the radiobiological modelling pro-
gram BioGray which allowed us to move from the dosimetric quantities to a biological 
effect of the doses [3]. Therefore, in the BioGray, we performed calculations of normal 
tissues complications probability (NTCP) as well as tumor control probability (TCP) 
that comprise information about the late complications. According to these probability 
values we compared both treatment plans for proton and photon therapy. 
The data obtained in the experiment show that the plans comparison based only on 
the dose distribution depicted on DVHs is not sufficient, whereas the radiobiological 
modelling makes it possible to calculate the probability of late effects through the 
NTCP and TCP. Eventually, it contributes to the determination of a radiation therapy 
strategy that is more likely to destroy the tumor while preserving the vital organs. 
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